| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 33,926,000 | 20,458,000 | 898,000 | 19,933,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 33,926,000 | 20,458,000 | 898,000 | 19,933,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 25,263,000 | 23,619,000 | 24,181,000 | 28,689,000 | | Non Recurring | 343,000 | 362,000 |
-
|
-
| | Others | 4,401,000 |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,919,000 | (3,523,000) | (23,283,000) | (8,756,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 3,919,000 | (3,523,000) | (23,283,000) | (8,756,000) | | Interest Expense | 2,600,000 | 2,845,000 | 4,902,000 |
-
| | Income Before Tax | 1,319,000 | (6,368,000) | (28,185,000) | (8,756,000) | | Income Tax Expense | (526,000) | (1,235,000) | (3,480,000) | (3,357,000) | | Minority Interest |
-
|
-
| 237,000 | 42,000 | | | | Net Income From Continuing Ops | 1,845,000 | (5,133,000) | (24,468,000) | (5,357,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,845,000 | (5,133,000) | (24,468,000) | (5,357,000) | | Preferred Stock And Other Adjustments | (23,000) | 780,000 |
-
|
-
| | | Net Income Applicable To Common Shares | $1,822,000 | ($4,353,000) | ($24,468,000) | ($5,357,000) |
|
0.17% Nasdaq 
3.80 (9.67%) 
Income Statement
